Therefore, it is important to intensify monitoring [132] and education of the child with type 1 diabetes submitted to insulin therapy, seeking to reduce the risks of hypoglycemia, particularly nocturnal hypoglycemia [2], hypoglycemia associated with exercise [133], and IIH during pregnancy [134]. This evidence concerns the gene INS and Hypoglycemia.